vimarsana.com
Home
Live Updates
Tiziana Life Sciences : Updated Interim Results for the Six Months Ended 30 June 2023 - Form 6-K -December 29, 2023 at 04:39 pm EST : comparemela.com
Tiziana Life Sciences : Updated Interim Results for the Six Months Ended 30 June 2023 - Form 6-K -December 29, 2023 at 04:39 pm EST
Updated Interim Results for the Six Months Ended 30 June 2023
NEW YORK, December 29, 2023 - Tiziana Life Sciences, Ltd. , a biotechnology company developing breakthrough...
Related Keywords
United States ,
United Kingdom ,
London ,
City Of ,
Bermuda ,
American ,
Tanuja Chitnis ,
Matthew Davis ,
Monte Carlo ,
Gabriele Cerrone ,
Saef Izzy ,
Williama Haseltine ,
Williama Clementi ,
Paul Spencer ,
Irina Koffler ,
Howard Weiner ,
Tiziana Life Sciences ,
Lifesci Advisors ,
Pharma Ltd ,
International Accounting Standards Board ,
International Conference On Alzheimer ,
Tiziana Life Sciences Ltda Bermudan ,
Investment In Related Party ,
Proceedings Of The National Academy Sciences ,
Tiziana Life Sciences Ltd ,
Ann Romney Center ,
American Academy Of Neurology ,
Investment In Accustem Sciences Inc ,
Clinical Program Updates ,
London Stock Exchange ,
Rasna Therapeutics Inc ,
Drug Administration ,
Planwise Ltd ,
Group Is Planwise Ltd ,
Business Development ,
Research In Multiple Sclerosis ,
Capital Market Exchange ,
Accustem Sciences Inc ,
International Financial Reporting Standards ,
Nasdaq ,
European Committee For Treatment ,
Updated Interim Results ,
Six Months Ended ,
Life Sciences ,
Executive Chairman ,
Chief Executive Officer ,
National Academy ,
Expanded Access ,
Expanded Disability Status Scale ,
Brigham Women ,
Mass General Brigham Healthcare System ,
International Conference ,
Related Neurological Disorders ,
Neurologic Diseases ,
Assistant Professor ,
Harvard Medical School ,
American Academy ,
Positron Emission Tomography ,
Year Operational ,
Chief Medical Officer ,
Chief Operating Officer ,
Acting Chief Executive Officer ,
Chief Development Officer ,
Clinical Program ,
Investigational New Drug ,
Modified Fatigue Impact Scale ,
Secondary Progressive Multiple Sclerosis ,
European Committee ,
Multiple Sclerosis ,
Device Training ,
Half Financial ,
Interim Report ,
Annual Report ,
Investor Relations ,
Sci Advisors ,
Related Party ,
Treasury Shares ,
Interim Financial ,
Life Sciences Ltd ,
Clarendon House ,
Tiziana Life Sciences Limited ,
Market Exchange ,
Intangible Assets ,
Convertible Loan Notes ,
Share Option Plan ,
Option Plan ,
Incentive Plan ,
Therapeutics Inc ,
Shared Services ,
Sciences Inc ,
Planwise Group ,
Markets ,
comparemela.com © 2020. All Rights Reserved.